Veracyte reported $1.19B in Assets for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Acceleron Pharma XLRN:US $ 787.85M 48.2M
Anika Therapeutics ANIK:US $ 352.93M 10.2M
Biocept BIOC:US $ 61.95M 11.34M
Bruker BRKR:US $ 3126M 39M
Dicerna Pharmaceuticals DRNA:US $ 772.06M 66.43M
Exact Sciences EXAS:US $ 6654.44M 69.9M
Genmark Diagnostics GNMK:US $ 223.53M 8.94M
Heron Therapeutics HRTX:US $ 352.39M 51.86M
Illumina ILMN:US $ 15063M 6388M
Immunogen IMGN:US $ 296.8M 4.64M
Intrexon XON:US $ 376.9M 25.67M
Karyopharm Therapeutics KPTI:US $ 254.09M 32.47M
Laboratory Of America LH:US $ 20866.5M 449.4M
Ligand Pharmaceuticals LGND:US $ 1273.66M 17.37M
Luminex LMNX:US $ 819.03M 6.43M
Myriad Genetics MYGN:US $ 1335.9M 24.4M
Rigel Pharmaceuticals RIGL:US $ 186.52M 15.08M
Sangamo Biosciences SGMO:US $ 772.4M 62.96M
Siemens SIE:GR € 139608M 2777M
Sonic Healthcare SHL:AU $ 11.76B 104.37M
Thermo Fisher Scientific TMO:US $ 73600M 5902M
Veracyte VCYT:US $ 1186.36M 158.92M
Waters WAT:US $ 3115.92M 12.27M